Literature DB >> 16772245

Exogenous insulin use and hypertension in adult patients with type 2 diabetes mellitus.

Chin-Hsiao Tseng1.   

Abstract

BACKGROUND: Endogenous hyperinsulinemia, along with insulin resistance, is associated with hypertension. This study investigated the link between exogenous insulin use and hypertension in patients with type 2 diabetes mellitus.
METHODS: Using national health insurance records in Taiwan, data from 87,850 adult patients with type 2 diabetes mellitus were collected cross-sectionally with retrospective recall for onset of events. Data were analyzed to evaluate the strength of association, consistency, dose-response relationship, and temporality between exogenous insulin use and hypertension.
RESULTS: There were 5927 insulin users, who were characterized by being 1 year older in age, female preponderance, longer duration of diabetes, slightly lower body mass index, and less smoking but higher prevalence of hypertension with higher blood pressure. After adjustment for age, sex, body mass index, duration of diabetes, smoking, and parental hypertension, the odds ratios (95% confidence interval [CI]) for hypertension for patients using insulin for less than 5 years, 5 to 9 years, and 10 years or more were 1.14 (95% CI, 1.06-1.23), 1.35 (95% CI, 1.18-1.54), and 1.46 (95% CI, 1.24-1.74), respectively, compared with nonusers. In insulin users who did not have hypertension at the start of insulin use, the respective odds ratios for those using insulin for 5 to 9 years and 10 years or more were 1.5 (95% CI, 1.25-1.80) and 2.15 (95% CI, 1.72-2.70), respectively, compared with those using insulin for less than 5 years.
CONCLUSIONS: In patients with type 2 diabetes mellitus, insulin users are at higher risk for development of hypertension. These observational data suggest the need for further study of the relationship between exogenous insulin use and hypertension.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772245     DOI: 10.1001/archinte.166.11.1184

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  13 in total

Review 1.  Effects of chronic hyperinsulinemia in insulin-resistant patients.

Authors:  Sergio Muntoni; Sandro Muntoni; Boris Draznin
Journal:  Curr Diab Rep       Date:  2008-06       Impact factor: 4.810

2.  Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery.

Authors:  Dale S Edgerton; Melanie Scott; Ben Farmer; Phillip E Williams; Peter Madsen; Thomas Kjeldsen; Christian L Brand; Christian Fledelius; Erica Nishimura; Alan D Cherrington
Journal:  JCI Insight       Date:  2019-02-26

3.  Type 2 diabetes, smoking, insulin use, and mortality from hepatocellular carcinoma: a 12-year follow-up of a national cohort in Taiwan.

Authors:  Chin-Hsiao Tseng
Journal:  Hepatol Int       Date:  2012-10-06       Impact factor: 6.047

4.  Relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR).

Authors:  Flavio E Hirai; Scot E Moss; Barbara E K Klein; Ronald Klein
Journal:  Diabetes Care       Date:  2007-11-19       Impact factor: 19.112

5.  Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006.

Authors:  C-H Tseng; C-K Chong; T-Y Tai
Journal:  Diabetologia       Date:  2008-11-19       Impact factor: 10.122

6.  The association between C-reactive protein levels and insulin therapy in obese vs nonobese veterans with type 2 diabetes mellitus.

Authors:  Sameed Ahmed M Khatana; Tracey H Taveira; Andrea G Dooley; Wen-Chih Wu
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-06       Impact factor: 3.738

7.  Prevalence and control of hypertension in iraqi diabetic patients: a prospective cohort study.

Authors:  Abbas Ali Mansour
Journal:  Open Cardiovasc Med J       Date:  2012-05-18

8.  Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage.

Authors:  Luis A Vázquez; Ángel Rodríguez; Javier Salvador; Juan F Ascaso; Helmut Petto; Jesús Reviriego
Journal:  BMC Cardiovasc Disord       Date:  2014-11-01       Impact factor: 2.298

9.  Factors Associated with Cancer- and Non-Cancer-Related Deaths among Taiwanese Patients with Diabetes after 17 Years of Follow-Up.

Authors:  Chin-Hsiao Tseng
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

10.  Changes in glucose and fat metabolism in response to the administration of a hepato-preferential insulin analog.

Authors:  Dale S Edgerton; Mary C Moore; Jason J Winnick; Melanie Scott; Ben Farmer; Helle Naver; Claus B Jeppesen; Peter Madsen; Thomas B Kjeldsen; Erica Nishimura; Christian L Brand; Alan D Cherrington
Journal:  Diabetes       Date:  2014-06-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.